Northwest Biotherapeutics Inc (NWBO) financial statements (2021 and earlier)

Company profile

Business Address 4800 MONTGOMERY LANE
BETHESDA, MD 20814
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:10022072213
Cash and cash equivalents10022062213
Other undisclosed cash, cash equivalents, and short-term investments    1  
Restricted cash and investments    111
Other undisclosed current assets6321010
Total current assets:16324182415
Noncurrent Assets
Operating lease, right-of-use asset45
Property, plant and equipment100004640
Intangible assets, net (including goodwill)2      
Goodwill1      
Intangible assets, net (excluding goodwill)1      
Restricted cash and investments     02
Deferred costs      2
Other noncurrent assets1110000
Other undisclosed noncurrent assets90 4745  
Total noncurrent assets:176148454744
TOTAL ASSETS:3392549537158
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:761613131317
Accounts payable    121216
Accrued liabilities    111
Other undisclosed accounts payable and accrued liabilities761613   
Debt267182111
Deferred compensation liability  0    
Derivative instruments and hedges, liabilities35520304052845
Accrued environmental loss contingencies   6666
Due to related parties 00705 
Business combination, contingent consideration, liability87     
Other undisclosed current liabilities9117331110
Total current liabilities:382417088766569
Noncurrent Liabilities
Long-term debt and lease obligation1312233 24
Long-term debt, excluding current maturities97233 24
Operating lease, liability55
Liabilities, other than long-term debt     06
Accrued environmental loss contingencies      6
Other liabilities     00
Other undisclosed noncurrent liabilities(5)  6 11(6)
Total noncurrent liabilities:13122931125
Total liabilities:396537296797593
Temporary equity, carrying amount      2
Stockholders' equity
Stockholders' equity attributable to parent, including:(363)(44)(47)(67)(26)(5)(35)
Common stock1110000
Common stock, share subscribed but unissued, subscriptions receivable(0)(0)(0)    
Additional paid in capital1,009795776722687631486
Accumulated other comprehensive income (loss)(1)11(1)2(0)(0)
Accumulated deficit(1,371)(840)(824)    
Other undisclosed stockholders' equity attributable to parent   (789)(715)(635)(521)
Other undisclosed stockholders' equity   20  (2)
Total stockholders' equity:(363)(44)(47)(47)(26)(5)(37)
TOTAL LIABILITIES AND EQUITY:3392549537158

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net0121
Gross profit:1200121
Operating expenses(88)(30)(42)(55)(80)(128)(120)
Other undisclosed operating income      17
Operating loss:(87)(27)(41)(55)(79)(126)(101)
Nonoperating income (expense)(443)765(12)00
Investment income, nonoperating    (6)  
Foreign currency transaction gain (loss), before tax   5(7)00
Other nonoperating income (expense)(443)76   0
Interest and debt expense(4)(2)0(20)(6)(2)(20)
Loss from continuing operations before income taxes:(534)(22)(36)(71)(98)(128)(121)
Income tax expense      (58)
Net loss:(534)(22)(36)(71)(98)(128)(178)
Other undisclosed net income (loss) attributable to parent42(0)(3)181443
Net loss attributable to parent:(530)(20)(36)(73)(80)(115)(136)
Other undisclosed net loss available to common stockholders, basic  (18)(1)(6)  
Net loss available to common stockholders, diluted:(530)(20)(54)(74)(86)(115)(136)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(534)(22)(36)(71)(98)(128)(178)
Other comprehensive income (loss)(2)(0)2(2)20 
Comprehensive loss:(536)(22)(34)(73)(96)(128)(178)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent42(0)(3)1814 
Comprehensive loss, net of tax, attributable to parent:(532)(20)(34)(76)(78)(115)(178)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: